Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies

被引:12
作者
Borges, Maria Beatriz J. [1 ]
Kato, Sayuri E. M. [2 ]
Damaso, Clarissa R. A. [2 ]
Moussatche, Nissin [2 ]
Freire, Marcos da Silva [1 ]
Lambert Passos, Sonia Regina [3 ]
do Nascimento, Jussara Pereira [1 ]
机构
[1] Bio Manguinhos FIOCRUZ, BR-21040900 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Mol Virus, BR-21941 Rio De Janeiro, RJ, Brazil
[3] Inst Pesquisa Clin Evandro Chagas FIOCRUZ, Lab Epidemiol Clin, Rio De Janeiro, RJ, Brazil
关键词
smallpox; microneutralization test; plaque reduction; international standard serum;
D O I
10.1016/j.biologicals.2007.07.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The detection of neutralizing antibodies against vaccinia virus is a valuable tool for the investigation of previous smallpox vaccination. Compulsory smallpox vaccination ended in Brazil during the early 1970s, although the vaccine was available until the late 1970s. The threat of smallpox as a biological weapon has called the attention of public health authorities to the need for an evaluation of the immune status of the population. Based on our previous experience with a micro plaque reduction neutralization test (PRNT) for the evaluation of yellow fever immunity, a similar test was developed for the detection and quantification of vaccinia neutralizing antibodies. A cross-sectional study to test the repeatability and validity of plaque reduction neutralization test (PRNT) for vaccinia antibodies was performed in 182 subjects divided into two categories: subjects above 31 years old and the other >= 35 years old. Cases were subjects considered to have been vaccinated with vaccinia virus if they declared vaccination history or evidenced vaccination marks. The assay is carried out in 96-well plates, provides results within 30 h, is easily performed, has good sensitivity (92.7%) and specificity (90.8), excellent repeatability (ICC 0.89 (0.88; 0.92)) and is thus suitable for use in mass screening of a population's antibody levels. (c) 2007 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 34 条
[1]   Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCE .
BRITISH MEDICAL JOURNAL, 2003, 326 (7379) :41-44
[2]   Comparison of seroconversion rates with CAM-70 measles vaccine at different dosages [J].
Camacho, LAB ;
Freire, MS ;
Yamamura, AMY ;
Leal, MD ;
Mann, G .
REVISTA DE SAUDE PUBLICA, 2000, 34 (04) :358-366
[3]   Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial [J].
Camacho, LAB ;
Freire, MD ;
Leal, MDL ;
de Aguiar, SG ;
do Nascimento, JP ;
Iguchi, T ;
Lozana, JD ;
Farias, RHG .
REVISTA DE SAUDE PUBLICA, 2004, 38 (05) :671-678
[4]  
CUTCHINS E, 1960, J IMMUNOL, V85, P275
[5]   A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil [J].
Damaso, Clarissa R. A. ;
Reis, Sheila A. ;
Jesus, Desyree M. ;
Lima, Patricia S. F. ;
Moussatche, Nissin .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 57 (01) :39-46
[6]   Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins [J].
Damaso, CRA ;
Moussatché, N .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :339-346
[7]   PROTEIN-SYNTHESIS IN VACCINIA VIRUS-INFECTED CELLS .1. EFFECT OF HYPERTONIC SHOCK RECOVERY [J].
DAMASO, CRA ;
MOUSSATCHE, N .
ARCHIVES OF VIROLOGY, 1992, 123 (3-4) :295-308
[8]   An emergent poxvirus from humans and cattle in Rio de Janeiro State:: Cantagalo virus may derive from Brazilian smallpox vaccine [J].
Damaso, CRA ;
Esposito, JJ ;
Condit, RC ;
Moussatché, N .
VIROLOGY, 2000, 277 (02) :439-449
[9]   CYCLOSPORINE-A INHIBITS VACCINIA VIRUS-REPLICATION IN-VITRO [J].
DAMASO, CRA ;
KELLER, SJ .
ARCHIVES OF VIROLOGY, 1994, 134 (3-4) :303-319
[10]   THE PERSISTENCE OF NEUTRALIZING ANTIBODIES AFTER REVACCINATION AGAINST SMALLPOX [J].
ELAD, B ;
ROTH, Y ;
WINDER, A ;
TOCHNER, Z ;
LUBLINTENNENBAUM, T ;
KATZ, E ;
SCHWARTZ, T .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) :446-448